Abbott Laboratories (ABT)
USD 111.93
(-1.2%)
USD 111.93
(-1.2%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 15.87 Billion USD | -10.4% |
| 2022 | 17.71 Billion USD | -6.79% |
| 2021 | 19 Billion USD | -3.27% |
| 2020 | 19.64 Billion USD | 4.0% |
| 2019 | 18.89 Billion USD | -3.43% |
| 2018 | 19.56 Billion USD | -29.93% |
| 2017 | 27.92 Billion USD | 26.89% |
| 2016 | 22 Billion USD | 144.48% |
| 2015 | 9 Billion USD | 14.74% |
| 2014 | 7.84 Billion USD | 19.57% |
| 2013 | 6.56 Billion USD | -67.96% |
| 2012 | 20.47 Billion USD | 32.84% |
| 2011 | 15.41 Billion USD | -18.52% |
| 2010 | 18.91 Billion USD | 14.96% |
| 2009 | 16.45 Billion USD | 43.78% |
| 2008 | 11.44 Billion USD | -6.29% |
| 2007 | 12.21 Billion USD | -1.59% |
| 2006 | 12.41 Billion USD | 87.09% |
| 2005 | 6.63 Billion USD | -2.17% |
| 2004 | 6.78 Billion USD | 13.2% |
| 2003 | 5.98 Billion USD | -6.74% |
| 2002 | 6.42 Billion USD | -11.88% |
| 2001 | 7.28 Billion USD | 368.49% |
| 2000 | 1.55 Billion USD | -30.33% |
| 1999 | 2.23 Billion USD | -27.94% |
| 1998 | 3.09 Billion USD | 13.95% |
| 1997 | 2.71 Billion USD | 17.38% |
| 1996 | 2.31 Billion USD | 56.0% |
| 1995 | 1.48 Billion USD | 40.15% |
| 1994 | 1.05 Billion USD | -7.9% |
| 1993 | 1.15 Billion USD | 12.1% |
| 1992 | 1.02 Billion USD | 53.32% |
| 1991 | 669.4 Million USD | -16.18% |
| 1990 | 798.6 Million USD | 78.58% |
| 1989 | 447.2 Million USD | -46.93% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | - USD | 1.53% |
| 2024 Q1 | 14.58 Billion USD | -8.11% |
| 2024 Q2 | 14.75 Billion USD | 1.15% |
| 2023 Q1 | 16.77 Billion USD | -5.32% |
| 2023 Q3 | 15.52 Billion USD | -7.82% |
| 2023 Q2 | 16.84 Billion USD | 0.44% |
| 2023 FY | 15.87 Billion USD | -10.4% |
| 2023 Q4 | 15.87 Billion USD | 2.22% |
| 2022 Q4 | 17.71 Billion USD | 7.93% |
| 2022 Q3 | 16.41 Billion USD | -2.06% |
| 2022 Q2 | 16.76 Billion USD | -1.93% |
| 2022 Q1 | 17.09 Billion USD | -10.08% |
| 2022 FY | 17.71 Billion USD | -6.79% |
| 2021 Q2 | 18.5 Billion USD | 0.31% |
| 2021 Q1 | 18.44 Billion USD | -6.13% |
| 2021 Q3 | 18.39 Billion USD | -0.56% |
| 2021 Q4 | 19 Billion USD | 3.31% |
| 2021 FY | 19 Billion USD | -3.27% |
| 2020 Q3 | 18.56 Billion USD | -5.67% |
| 2020 FY | 19.64 Billion USD | 4.0% |
| 2020 Q4 | 19.64 Billion USD | 5.85% |
| 2020 Q1 | 18.27 Billion USD | -3.29% |
| 2020 Q2 | 19.67 Billion USD | 7.7% |
| 2019 FY | 18.89 Billion USD | -3.43% |
| 2019 Q1 | 19.05 Billion USD | -2.62% |
| 2019 Q2 | 19.19 Billion USD | 0.73% |
| 2019 Q3 | 19.09 Billion USD | -0.51% |
| 2019 Q4 | 18.89 Billion USD | -1.06% |
| 2018 Q4 | 19.56 Billion USD | -16.95% |
| 2018 Q3 | 23.55 Billion USD | 13.97% |
| 2018 Q2 | 20.67 Billion USD | -5.58% |
| 2018 Q1 | 21.89 Billion USD | -21.61% |
| 2018 FY | 19.56 Billion USD | -29.93% |
| 2017 Q1 | 23.97 Billion USD | 8.94% |
| 2017 FY | 27.92 Billion USD | 26.89% |
| 2017 Q4 | 27.92 Billion USD | 16.23% |
| 2017 Q3 | 24.02 Billion USD | -0.02% |
| 2017 Q2 | 24.03 Billion USD | 0.24% |
| 2016 Q2 | 8.91 Billion USD | 3.75% |
| 2016 Q1 | 8.59 Billion USD | -4.57% |
| 2016 Q4 | 22 Billion USD | 158.59% |
| 2016 Q3 | 8.51 Billion USD | -4.51% |
| 2016 FY | 22 Billion USD | 144.48% |
| 2015 Q4 | 9 Billion USD | 7.73% |
| 2015 FY | 9 Billion USD | 14.74% |
| 2015 Q1 | 8.9 Billion USD | 13.49% |
| 2015 Q2 | 8.76 Billion USD | -1.59% |
| 2015 Q3 | 8.35 Billion USD | -4.63% |
| 2014 Q3 | 8.3 Billion USD | 12.71% |
| 2014 Q2 | 7.36 Billion USD | -5.15% |
| 2014 FY | 7.84 Billion USD | 19.57% |
| 2014 Q4 | 7.84 Billion USD | -5.49% |
| 2014 Q1 | 7.76 Billion USD | 18.35% |
| 2013 Q1 | 7.1 Billion USD | -65.31% |
| 2013 Q4 | 6.56 Billion USD | -20.6% |
| 2013 FY | 6.56 Billion USD | -67.96% |
| 2013 Q3 | 8.26 Billion USD | 4.14% |
| 2013 Q2 | 7.93 Billion USD | 11.72% |
| 2012 FY | 20.47 Billion USD | 32.84% |
| 2012 Q4 | 20.47 Billion USD | 25.78% |
| 2012 Q3 | 16.27 Billion USD | -9.99% |
| 2012 Q2 | 18.08 Billion USD | 8.65% |
| 2012 Q1 | 16.64 Billion USD | 7.99% |
| 2011 Q3 | 16.72 Billion USD | -8.22% |
| 2011 Q4 | 15.41 Billion USD | -7.81% |
| 2011 Q2 | 18.21 Billion USD | -3.0% |
| 2011 Q1 | 18.78 Billion USD | -0.72% |
| 2011 FY | 15.41 Billion USD | -18.52% |
| 2010 Q4 | 18.91 Billion USD | 1.08% |
| 2010 Q2 | 18.48 Billion USD | 6.66% |
| 2010 FY | 18.91 Billion USD | 14.96% |
| 2010 Q1 | 17.32 Billion USD | 5.29% |
| 2010 Q3 | 18.71 Billion USD | 1.28% |
| 2009 Q2 | 15.7 Billion USD | -0.07% |
| 2009 Q1 | 15.71 Billion USD | 37.3% |
| 2009 FY | 16.45 Billion USD | 43.78% |
| 2009 Q3 | 15.65 Billion USD | -0.31% |
| 2009 Q4 | 16.45 Billion USD | 5.12% |
| 2008 Q1 | 13.22 Billion USD | 8.26% |
| 2008 Q2 | 13.88 Billion USD | 5.02% |
| 2008 Q4 | 11.44 Billion USD | 0.74% |
| 2008 FY | 11.44 Billion USD | -6.29% |
| 2008 Q3 | 11.36 Billion USD | -18.18% |
| 2007 FY | 12.21 Billion USD | -1.59% |
| 2007 Q3 | 12.24 Billion USD | -0.69% |
| 2007 Q1 | 12.47 Billion USD | 0.53% |
| 2007 Q2 | 12.32 Billion USD | -1.2% |
| 2007 Q4 | 12.21 Billion USD | -0.23% |
| 2006 Q1 | 6.29 Billion USD | -5.14% |
| 2006 Q4 | 12.41 Billion USD | 31.4% |
| 2006 Q2 | 10.42 Billion USD | 65.69% |
| 2006 FY | 12.41 Billion USD | 87.09% |
| 2006 Q3 | 9.44 Billion USD | -9.41% |
| 2005 Q4 | 6.63 Billion USD | 0.78% |
| 2005 FY | 6.63 Billion USD | -2.17% |
| 2005 Q3 | 6.58 Billion USD | 14.74% |
| 2005 Q2 | 5.73 Billion USD | -20.05% |
| 2005 Q1 | 7.17 Billion USD | 5.83% |
| 2004 Q4 | 6.78 Billion USD | 3.02% |
| 2004 FY | 6.78 Billion USD | 13.2% |
| 2004 Q1 | 6.68 Billion USD | 11.61% |
| 2004 Q2 | 6.96 Billion USD | 4.22% |
| 2004 Q3 | 6.58 Billion USD | -5.53% |
| 2003 Q1 | 6.46 Billion USD | 0.73% |
| 2003 Q2 | 6.14 Billion USD | -5.02% |
| 2003 Q3 | 6.62 Billion USD | 7.86% |
| 2003 Q4 | 5.98 Billion USD | -9.62% |
| 2003 FY | 5.98 Billion USD | -6.74% |
| 2002 Q1 | 6.9 Billion USD | -5.33% |
| 2002 Q4 | 6.42 Billion USD | -7.41% |
| 2002 Q3 | 6.93 Billion USD | 2.14% |
| 2002 FY | 6.42 Billion USD | -11.88% |
| 2002 Q2 | 6.79 Billion USD | -1.58% |
| 2001 FY | 7.28 Billion USD | 368.49% |
| 2001 Q4 | 7.28 Billion USD | 0.48% |
| 2001 Q3 | 7.25 Billion USD | -3.95% |
| 2001 Q2 | 7.55 Billion USD | 7.24% |
| 2001 Q1 | 7.04 Billion USD | 352.7% |
| 2000 Q2 | 1.68 Billion USD | -24.77% |
| 2000 FY | 1.55 Billion USD | -30.33% |
| 2000 Q3 | 1.62 Billion USD | -3.49% |
| 2000 Q4 | 1.55 Billion USD | -4.16% |
| 2000 Q1 | 2.23 Billion USD | 0.13% |
| 1999 Q1 | 2.62 Billion USD | -15.26% |
| 1999 Q2 | 2.32 Billion USD | -11.63% |
| 1999 Q3 | 2.2 Billion USD | -4.79% |
| 1999 Q4 | 2.23 Billion USD | 1.08% |
| 1999 FY | 2.23 Billion USD | -27.94% |
| 1998 Q2 | 2.71 Billion USD | 11.79% |
| 1998 Q3 | 2.76 Billion USD | 1.62% |
| 1998 FY | 3.09 Billion USD | 13.95% |
| 1998 Q4 | 3.09 Billion USD | 12.24% |
| 1998 Q1 | 2.43 Billion USD | -10.63% |
| 1997 FY | 2.71 Billion USD | 17.38% |
| 1997 Q4 | 2.71 Billion USD | 5.51% |
| 1997 Q1 | 2.13 Billion USD | -7.92% |
| 1997 Q2 | 2.39 Billion USD | 12.22% |
| 1997 Q3 | 2.57 Billion USD | 7.66% |
| 1996 Q1 | 1.1 Billion USD | -25.32% |
| 1996 Q3 | 2.13 Billion USD | 1.41% |
| 1996 Q2 | 2.1 Billion USD | 89.71% |
| 1996 Q4 | 2.31 Billion USD | 8.57% |
| 1996 FY | 2.31 Billion USD | 56.0% |
| 1995 Q1 | 1.16 Billion USD | 10.33% |
| 1995 FY | 1.48 Billion USD | 40.15% |
| 1995 Q2 | 1.26 Billion USD | 8.23% |
| 1995 Q4 | 1.48 Billion USD | 8.2% |
| 1995 Q3 | 1.37 Billion USD | 8.47% |
| 1994 Q2 | 1.05 Billion USD | 7.21% |
| 1994 Q1 | 982.28 Million USD | -14.62% |
| 1994 Q3 | 1.07 Billion USD | 1.81% |
| 1994 Q4 | 1.05 Billion USD | -1.17% |
| 1994 FY | 1.05 Billion USD | -7.9% |
| 1993 Q1 | 981 Million USD | -4.41% |
| 1993 Q2 | 1.11 Billion USD | 13.33% |
| 1993 Q3 | 1.07 Billion USD | -2.87% |
| 1993 Q4 | 1.15 Billion USD | 6.53% |
| 1993 FY | 1.15 Billion USD | 12.1% |
| 1992 Q3 | 952.6 Million USD | 49.1% |
| 1992 Q1 | 795.3 Million USD | 18.81% |
| 1992 Q2 | 638.9 Million USD | -19.67% |
| 1992 Q4 | 1.02 Billion USD | 7.74% |
| 1992 FY | 1.02 Billion USD | 53.32% |
| 1991 Q1 | 715.8 Million USD | -10.37% |
| 1991 Q3 | 665.2 Million USD | -7.55% |
| 1991 Q4 | 669.4 Million USD | 0.63% |
| 1991 FY | 669.4 Million USD | -16.18% |
| 1991 Q2 | 719.5 Million USD | 0.52% |
| 1990 Q1 | 685.4 Million USD | 53.26% |
| 1990 Q3 | 1.07 Billion USD | 21.36% |
| 1990 Q2 | 883.4 Million USD | 28.89% |
| 1990 FY | 798.6 Million USD | 78.58% |
| 1990 Q4 | 798.6 Million USD | -25.51% |
| 1989 Q4 | 447.2 Million USD | 0.0% |
| 1989 FY | 447.2 Million USD | -46.93% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Allurion Technologies Inc. | 41.85 Million USD | -37821.972% |
| Artivion, Inc. | 359.34 Million USD | -4317.253% |
| Avanos Medical, Inc. | 209.1 Million USD | -7491.105% |
| Butterfly Network, Inc. | 25.02 Million USD | -63323.503% |
| Butterfly Network, Inc. | 25.02 Million USD | -63323.503% |
| Bio-Rad Laboratories, Inc. | 1.4 Billion USD | -1029.032% |
| Boston Scientific Corporation | 9.49 Billion USD | -67.225% |
| Perspective Therapeutics, Inc. | - USD | -Infinity% |
| CONMED Corporation | 991.25 Million USD | -1501.305% |
| Edwards Lifesciences Corporation | 694.9 Million USD | -2184.214% |
| Paragon 28, Inc. | 112.03 Million USD | -14068.526% |
| Glaukos Corporation | 383.73 Million USD | -4036.416% |
| Globus Medical, Inc. | 520.4 Million USD | -2950.13% |
| Inspire Medical Systems, Inc. | 24.84 Million USD | -63785.535% |
| Integer Holdings Corporation | 1.04 Billion USD | -1424.848% |
| Medtronic plc | 26.04 Billion USD | 39.06% |
| Nevro Corp. | 221.82 Million USD | -7055.576% |
| Owlet, Inc. | 15.21 Million USD | -104217.823% |
| Penumbra, Inc. | 234.34 Million USD | -6673.405% |
| Vicarious Surgical Inc. | 14.83 Million USD | -106918.608% |
| Smith & Nephew plc | 3.08 Billion USD | -414.689% |
| Sonendo, Inc. | 40.35 Million USD | -39237.315% |
| STERIS plc | 3.38 Billion USD | -369.176% |
| Stryker Corporation | 12.99 Billion USD | -22.147% |
| Vapotherm, Inc. | 112.39 Million USD | -14022.891% |
| Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | -164.762% |